We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel (ANTARCTIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01538446
Recruitment Status : Completed
First Posted : February 24, 2012
Last Update Posted : January 11, 2017
Eli Lilly and Company
Daiichi Sankyo, Inc.
Allies in Cardiovascular Trials Initiatives and Organized
Accumetrics, Inc.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : May 2016
  Study Completion Date : May 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):